Joseph Moskowitz Sells 12,370 Shares of Aflac (NYSE:AFL) Stock
π Director Joseph Moskowitz sold 12,370 shares of Aflac for $1.44 million, reducing his personal ownership by 27.08%.
π° The company reported Q1 revenue of $4.24 billion, surpassing analyst expectations of $4.20 billion.
π Earnings per share came in at $1.75, missing the consensus estimate of $1.80 by $0.05.
π Revenue grew 27.9% year-over-year compared to the same quarter in the prior fiscal year.
π¦ Morgan Stanley raised its price target to $125.00 and maintained an 'equal weight' rating on the stock.
π Evercore upgraded Aflac from a 'strong sell' to a 'strong-buy' rating in April.
π Wall Street Zen upgraded the stock from 'sell' to 'hold' following recent performance data.
ποΈ Institutional ownership stands at 67.44%, with hedge funds increasing stakes significantly in Q1.
π The stock currently trades with a PE ratio of 13.40 and a market capitalization of $60.08 billion.
π Analyst consensus target price is set at $112.27, slightly below the current trading levels.
- Aflac reported revenue of $4.24 billion for the quarter, exceeding analyst estimates of $4.20 billion.
- The company achieved a net margin of 25.60% and a return on equity of 13.88% during the reporting period.
- Revenue increased by 27.9% compared to the same quarter in the prior year, indicating strong top-line growth.
- Evercore upgraded its rating from 'strong sell' to 'strong-buy', signaling a significant shift in analyst sentiment.
- Morgan Stanley raised its price objective from $120.00 to $125.00, reflecting confidence in future performance.
- Wall Street Zen upgraded the stock from a 'sell' rating to a 'hold', improving the overall analyst outlook.
- Institutional investors like Western Wealth Management and Empowered Funds significantly increased their holdings in Q1.
- Aflac missed quarterly earnings estimates by $0.05 per share, reporting EPS of $1.75 against a consensus of $1.80.
- The stock currently trades below the average analyst price target of $112.27 according to MarketBeat data.
- UBS Group lowered its price target from $116.00 to $114.00 and assigned a 'neutral' rating to the stock.
- Six out of twelve analysts currently rate the stock as a 'Hold', indicating a lack of strong consensus bullishness.